Trials / Completed
CompletedNCT02487914
Evaluation of Pressure Sense Threshold and Tactile Sensation After Lidocaine Iontophoresis Using Interferential Current
Iontophoresis Effects on Senses
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Shiraz University of Medical Sciences · Academic / Other
- Sex
- Female
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
Drug delivery is conducted through various methods such as injection, phonophoresis, and iontophoresis. Iontophoresis is defined as the noninvasive delivery of active ions through epidermis using direct current. The direct current has some disadvantages such as skin burning and limited time of application. Interferential current is a kind of alternating currents without limitations of direct current; so the purpose of this study was to investigate and compare the effects of Lidocaine, interferential current and Lidocaine iontophoresis using interferential current.
Detailed description
Pressure, tactile, and pain thresholds were evaluated before and after the application of Lidocaine, interferential current and Lidocaine iontophoresis using interferential current. Pressure threshold was investigated with a Pesula. Pesula is a pen-like scaled mechanical device that measures the skin pressure threshold. Pesula was pressed to the skin and pressure threshold was measured in mm. Pain and tactile thresholds were investigated using an electrical stimulator.The intensity was gradually increased to the extent that the participant reported a tingling sensation. The displayed intensity was considered as the tactile sense threshold. Then, the intensity was increased to the extent to be intolerable for the participant and this intensity was considered as the maximum pain threshold. The thresholds were recorded in milliampere. Lidocaine iontophoresis using interferential current can increase perception threshold of pain, and pressure sense more significantly in comparison to the application of Lidocaine and interferential current alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iontophoresis of Lidocaine 10% with interferential current (Dynatron 438) | drug delivery through interferential current. |
| DRUG | Lidocaine 10% was sprayed at the identified region | |
| DEVICE | interferential current |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2014-03-01
- Completion
- 2015-03-01
- First posted
- 2015-07-02
- Last updated
- 2015-07-02
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT02487914. Inclusion in this directory is not an endorsement.